Vaccinex Statistics
Total Valuation
Vaccinex has a market cap or net worth of 2.01 million. The enterprise value is 682,477.
Market Cap | 2.01M |
Enterprise Value | 682,477 |
Important Dates
The last earnings date was Thursday, March 20, 2025.
Earnings Date | Mar 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Vaccinex has 2.68 million shares outstanding. The number of shares has increased by 480.32% in one year.
Current Share Class | n/a |
Shares Outstanding | 2.68M |
Shares Change (YoY) | +480.32% |
Shares Change (QoQ) | +11.52% |
Owned by Insiders (%) | 0.40% |
Owned by Institutions (%) | 0.64% |
Float | 1.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.99 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.04 |
EV / Sales | 1.76 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.04 |
Financial Position
The company has a current ratio of 0.77
Current Ratio | 0.77 |
Quick Ratio | 0.63 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -0.00 |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -342.96% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 1,539.44% |
Revenue Per Employee | 9,949 |
Profits Per Employee | -476,333 |
Employee Count | 40 |
Asset Turnover | 0.10 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.50% in the last 52 weeks. The beta is 1.28, so Vaccinex's price volatility has been higher than the market average.
Beta (5Y) | 1.28 |
52-Week Price Change | -86.50% |
50-Day Moving Average | 0.97 |
200-Day Moving Average | 3.41 |
Relative Strength Index (RSI) | 58.07 |
Average Volume (20 Days) | 5,572 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.84 |
Income Statement
In the last 12 months, Vaccinex had revenue of 388,000 and -18.58 million in losses. Loss per share was -12.02.
Revenue | 388,000 |
Gross Profit | -16.19M |
Operating Income | -20.34M |
Pretax Income | -18.58M |
Net Income | -18.58M |
EBITDA | -20.23M |
EBIT | -20.34M |
Loss Per Share | -12.02 |
Balance Sheet
The company has 2.91 million in cash and 59,000 in debt, giving a net cash position of 2.85 million or 1.06 per share.
Cash & Cash Equivalents | 2.91M |
Total Debt | 59,000 |
Net Cash | 2.85M |
Net Cash Per Share | 1.06 |
Equity (Book Value) | -1.32M |
Book Value Per Share | -1.09 |
Working Capital | -1.42M |
Cash Flow
In the last 12 months, operating cash flow was -15.85 million and capital expenditures -22,000, giving a free cash flow of -15.87 million.
Operating Cash Flow | -15.85M |
Capital Expenditures | -22,000 |
Free Cash Flow | -15.87M |
FCF Per Share | -5.93 |
Margins
Gross Margin | n/a |
Operating Margin | -5,241.24% |
Pretax Margin | -4,787.89% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Vaccinex does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -480.32% |
Shareholder Yield | -480.32% |
Earnings Yield | -925.39% |
FCF Yield | -790.44% |
Stock Splits
The last stock split was on February 20, 2024. It was a reverse split with a ratio of 0.0714286.
Last Split Date | Feb 20, 2024 |
Split Type | Reverse |
Split Ratio | 0.0714286 |
Scores
Vaccinex has an Altman Z-Score of -115.62. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -115.62 |
Piotroski F-Score | n/a |